Pedro Cano‐Soldado

Interaction of Nucleoside Inhibitors of HIV-1 Reverse Transcriptase with the Concentrative Nucleoside Transporter-1 (Slc28A1)

Pedro Cano‐Soldado, Ignacio M. Larráyoz, Míriam Molina‐Arcas et al. · Antiviral Therapy · 2004 · 46 citations · Full text

Molecular Biology, Pharmacotherapy, Antiviral Drug +18

Concentrative nucleoside transporter 1 (hCNT1) promotes phenotypic changes relevant to tumor biology in a translocation-independent manner

Sandra Pérez‐Torras, Anna Vidal-Pla, Pedro Cano‐Soldado et al. · Cell Death and Disease · 2013 · 35 citations · Full text

Cancer Biology, Tumor Biology, Hcnt1 Expression +19

Human equilibrative nucleoside transporter-1 (hENT1) is required for the transcriptomic response of the nucleoside-derived drug 5′-DFUR in breast cancer MCF7 cells

Míriam Molina‐Arcas, Gema Moreno‐Bueno, Pedro Cano‐Soldado et al. · Biochemical Pharmacology · 2006 · 30 citations

Breast Oncology, Transcriptomic Response, Medicine +9

Functional Characterization of a Nucleoside-Derived Drug Transporter Variant (hCNT3 ) Showing Altered Sodium-Binding Capacity

Ekaitz Errasti‐Murugarren, Pedro Cano‐Soldado, Marçal Pastor‐Anglada et al. · Molecular Pharmacology · 2007 · 30 citations

Altered Expression of Nucleoside Transporter Genes (SLC28 and SLC29) in Adipose Tissue from HIV-1–Infected Patients

Jordi P Guallar, Pedro Cano‐Soldado, Ivette Aymerich et al. · Antiviral Therapy · 2007 · 26 citations